Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2015

View Archived Issues

Cyclic pyranopterin monophosphate substitution in neonates with molybdenum cofactor deficiency

Preclinical findings for NanoBio's intranasal nanoemulsion adjuvanted chlamydia vaccine

Morphotek and University of Wisconsin-Madison to study farletuzumab

Interim data released from phase II study of KRN-23 for XLH, phase III study enrolls first patient

Pluristem and Fukushima Medical University sign MOU for collaboration to study PLX-R18 for ARS

First patient recruited in phase II/III trial of Toca-511/Toca-FC in high-grade glioma

Coordinated delivery of anticancer drug combinations reduces toxicity

Texas Biomedical Research Institute receives NIH grant to develop cure for HIV infection in infants

Stem Cell Medicine, Ramot and Yeda sign license agreement for stem cell treatments

Intravenous Taigexyn achieves primary endpoint in phase III trial in community-acquired pneumonia

Fluorescent tracer MB-102 devised for noninvasive glomerular filtration rate measurement

Novavax initiates phase III trial of RSV F vaccine

Biotest cleared for phase III evaluation of BT-524 fibrinogen concentrate

Cytos Biotechnology and Kuros Biosurgery combine to create Kuros Biosciences

EMA validates Gilead's MAA for fixed-dose sofosbuvir/velpatasvir

New inhibitors block Ewing's sarcoma cell growth in vitro and in vivo

Radiation sensitizer NVX-108 receives FDA orphan drug designation

Calibr discloses integrin alphavbeta6 receptor antagonists

MUSC Foundation for Research Development patents anticancer agents

Molecular Targeting Technologies and NHRI develop anticancer drug conjugates

SpsB inhibitors reported in RQx Pharmaceuticals patent

Genentech and Roche report retinoid RORgamma ligands

Sealife Pharma presents antibacterial agents

Multiple dosing begun in phase I trial of CCX-872-B in pancreatic cancer

Samsung Bioepis obtains Korean approval for Renflexis and updates pipeline status

First-in-human data for ASTX-727 in myelodysplastic syndromes presented at ASH

Eli Lilly to cease development of basal insulin peglispro

Consortium invests in Athera Biotechnologies to further development of PC-mAB

First response to a BET inhibitor seen in NUT midline carcinoma

Zymeworks and GSK enter collaboration and license agreement for Fc-engineered antibodies

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...